Trimedyne (TMED) 10-K 13 Jan 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Sep. 30, 2014	Jan. 14, 2015	Jan. 13, 2015
Document And Entity Information
Entity Registrant Name	TRIMEDYNE INC
Entity Central Index Key	357001
Document Type	10-K
Document Period End Date	30-Sep-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-21
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$800,874
Entity Common Stock, Shares Outstanding		18,395,960
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Sep. 30, 2013
Current assets:
Cash and cash equivalents	$1,292,000	$1,572,000
Trade accounts receivable, net of allowance for doubtful accounts of $11,000 for 2014 and 2013	463,000	475,000
Inventories	1,581,000	1,201,000
Other current assets	123,000	166,000
Total current assets	3,459,000	3,414,000
Property and equipment, net	635,000	706,000
Other	73,000	37,000
Goodwill	544,000	544,000
Total Assets	4,711,000	4,701,000
Current liabilities:
Accounts payable	278,000	177,000
Accrued expenses	628,000	416,000
Deferred revenue	50,000	37,000
Accrued warranty	27,000	16,000
Taxes Payable	0	8,000
Current portion of note payable and capital leases	70,000	49,000
Total current liabilities	1,053,000	703,000
Deferred rent	6,000	11,000
Long-term debt	43,000	0
Total liabilities	1,102,000	714,000
Commitments and contingencies
Stockholders' equity:
Preferred stock - $0.01 par value, 1,000,000 shares authorized, none issued and outstanding	0	0
Common stock - $0.01 par value; 30,000,000 shares authorized, 18,497,569 shares issued, 18,395,960 shares outstanding at September 30, 2014 and 2013	186,000	186,000
Additional paid-in capital	51,311,000	51,308,000
Accumulated deficit	-47,175,000	-46,794,000
Stockholders' Equity before Treasury Stock	4,322,000	4,700,000
Treasury stock, at cost (101,609 shares)	-713,000	-713,000
Total stockholders' equity	3,609,000	3,987,000
Total liabilities and stockholder's equity	$4,711,000	$4,701,000

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$11,000	$11,000
Preferred stock par value	$0.01	$0.01
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock par value	$0.01	$0.01
Common stock shares authorized	30,000,000	30,000,000
Common stock shares issued	18,497,569	18,497,569
Common stock shares outstanding	18,395,960	18,395,960
Treasury stock shares	101,609	101,609

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net revenues:
Products	$2,950,000	$3,130,000
Service and rental	2,511,000	2,859,000
Net revenues	5,461,000	5,989,000
Cost of sales:
Products	1,776,000	1,721,000
Service and rental	1,738,000	1,900,000
Cost of sales	3,514,000	3,621,000
Gross profit	1,947,000	2,368,000
Operating expenses:
Selling, general and administrative	1,942,000	2,329,000
Research and development	471,000	407,000
Loss from operations	-466,000	-368,000
Other income (expense):
Royalty income	78,000	98,000
Interest expense	-10,000	-2,000
Settlements and other	24,000	610,000
Net gain on disposal of assets	0	8,000
Total other income, net	92,000	714,000
Income (loss) before provision for income taxes	-374,000	346,000
Provision for income taxes	7,000	17,000
Net income (loss)	($381,000)	$329,000
Basic net income (loss) per share	($0.02)	$0.02
Diluted net income (loss) per share	($0.02)	$0.02
Basic weighted average common shares outstanding	18,395,960	18,395,960
Diluted weighted average common shares outstanding	18,395,960	18,395,960

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings / Accumulated Deficit [Member]	Treasury Stock [Member]	Total
Beginning balance, value at Sep. 30, 2012	$186,000	$51,295,000	($47,123,000)	($713,000)	$3,645,000
Beginning balance, shares at Sep. 30, 2012	18,497,569
Share-based compensation expense		13,000			13,000
Net income (loss)			329,000		329,000
Ending balance, value at Sep. 30, 2013	186,000	51,308,000	-46,794,000	-713,000	3,987,000
Ending balance, shares at Sep. 30, 2013	18,497,569
Share-based compensation expense		3,000			3,000
Net income (loss)			-381,000		-381,000
Ending balance, value at Sep. 30, 2014	$186,000	$51,311,000	($47,175,000)	($713,000)	$3,609,000
Ending balance, shares at Sep. 30, 2014	18,497,569

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net (loss) income	($381,000)	$329,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Stock-based compensation	3,000	13,000
Depreciation and amortization	218,000	241,000
Gain on disposal of fixed assets	0	-8,000
Changes in operating assets and liabilities:
Trade accounts receivable	12,000	18,000
Inventories	-380,000	646,000
Other assets	101,000	150,000
Accounts payable	101,000	28,000
Accrued expenses	212,000	64,000
Deferred revenue	13,000	-16,000
Accrued warranty	11,000	-7,000
Deferred rent	-5,000	-32,000
Taxes payable	-8,000	8,000
Net cash (used in) provided by operating activities	-103,000	1,434,000
Cash flows from investing activities:
Purchase of property and equipment	-28,000	-188,000
Net cash used in investing activities	-28,000	-188,000
Cash flows from financing activities:
Principal payments on note payable and capital leases	-149,000	-146,000
Net cash used in financing activities	-149,000	-146,000
Net increase (decrease) in cash and cash equivalents	-280,000	1,100,000
Cash and cash equivalents at beginning of year	1,572,000	472,000
Cash and cash equivalents at end of year	1,292,000	1,572,000
Supplemental disclosure of cash flow information:
Cash paid for income taxes	12,000	11,000
Cash paid for interest	10,000	2,000
Supplemental disclosure of non-cash investing activity:
Company financing of insurance policies	83,000	126,000
Financed for the upgrading of IT infrastructure	$119,000	$0

1_Organization_and_Business

1. Organization and Business	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
1. Organization and Business	Trimedyne, Inc. ("Trimedyne") and its subsidiaries (collectively "the Company") are engaged primarily in the manufacture and sale of lasers, and disposable and reusable fiber-optic laser devices in the medical field. The Company's operations include the provision of services and rental of lasers and other medical equipment to hospitals and surgery centers on a "fee-per-case" basis in the Southwestern United States, through its wholly owned subsidiary Mobile Surgical Technologies, Inc. ("MST"), located in Dallas, Texas. The Company's operations are primarily located in Southern California with distribution of its products worldwide (see Note 9).
	At September 30, 2014, we had working capital of $2,406,000 compared to $2,711,000 at the end of the previous fiscal year ended September 30, 2013. Cash decreased by $280,000 to $1,292,000 at September 30, 2014 from $1,572,000 at the fiscal year ended September 30, 2013.
	The Company is currently pursuing market development efforts in growth markets in Asia, Latin America and Eastern Europe. We believe that by expanding healthcare infrastructure in these markets, we may be able to create a sustained demand for Holmium Lasers applied to Spinal Endoscopy, Laser Lithotripsy and Laser prostate ablation. Additionally, we expect the global trend toward single-use disposable laser delivery products will improve sales and profit margins as more hospitals convert from multi-use products, due to concerns for sterility and interests to reduce handling costs incurred in product sterilization, and we are developing more single-use products.

2_Summary_Of_Significant_Accou

2. Summary Of Significant Accounting Policies	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
2. Summary Of Significant Accounting Policies	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of Trimedyne, Inc., its wholly owned subsidiary, MST, Inc., and its 90% owned and inactive subsidiary, Cardiodyne, Inc. ("Cardiodyne").  All intercompany accounts and transactions have been eliminated in consolidation.
	Concentration of Credit Risk and Customer Concentration
	The Company generates revenues principally from sales of products in the medical field. As a result, the Company's trade accounts receivable are concentrated primarily in this industry. The Company performs limited credit evaluations of its customers and generally does not require collateral. The Company maintains reserves for potential credit losses. The Company considers the following factors when determining if collection of a fee is reasonably assured: customer credit-worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment terms. In some cases in regards to new customers, management requires payment in full or letters of credit before goods are shipped or services are performed. If these factors do not indicate collection is reasonably assured, revenue is deferred until collection becomes reasonably assured, which is generally upon receipt of cash. During fiscal 2014 and 2013, credit losses were not significant.
	During the current fiscal year ended 2014, the Company had sales to two customers, which represented approximately 30% of product sales. During the fiscal year ended 2013, the Company had sales to one customer, which represented approximately 11% of product sales. During the fiscal years ended September 30, 2014 and 2013, there were no concentrations of service and rental sales.
	If the relationship between the Company and these customers was altered, the futures results of operations and financial condition could be significantly affected. Additionally, during fiscal 2014 and 2013, export sales approximated 23.0% and 19.0% of sales, respectively.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with insignificant interest rate risk and original maturities of three months or less from the date of purchase to be cash equivalents. The carrying amounts of cash and cash equivalents approximate their fair values.
	At September 30, 2014, the Company had cash balances in excess of federally insured limits of $250,000 in the amount of $972,000.
	Inventories
	Inventories consist of raw materials and component parts, work-in-process and finished goods consisting of lasers and dispensing systems. Inventories are recorded at the lower of cost or market, cost being determined principally by use of the average-cost method, which approximates the first-in, first-out method. Cost is determined at the actual cost for raw materials, and at production cost (materials, labor and indirect manufacturing overhead) for work-in-process and finished goods.
	Laser units located at medical facilities for sales evaluation and demonstration purposes or those units used for development and medical training are included in inventory since the lasers will ultimately be sold. These units are written down to reflect their net realizable values. Write-downs are considered permanent reductions at cost basis of the related inventories.
	Goodwill
	The Company accounts for goodwill and acquired intangible assets in accordance with Accounting Standards Codification (“ASC”) ASC No. 350 "Intangible and Other", whereby goodwill is not amortized, and is tested for impairment at the reporting unit level annually during the fourth quarter and in interim periods if certain events occur indicating that the carrying value of goodwill may be impaired. A reporting unit is an operating segment for which discrete financial information is available and is regularly reviewed by management. The Company has one reporting unit, our service and rental group, to which goodwill is assigned.
	ASC No. 350 requires a two-step approach to test goodwill for impairment for each reporting unit. The first step tests for impairment by applying fair value-based tests to a reporting unit. The second step, if deemed necessary, measures the impairment by applying fair value-based tests to specific assets and liabilities within the reporting unit. Application of the goodwill impairment tests require judgment, including identification of reporting units, assignment of assets and liabilities to each reporting unit, assignment of goodwill to each reporting unit, and determination of the fair value of each reporting unit. The determination of fair value for a reporting unit could be materially affected by changes in these estimates and assumptions.
	We concluded that it was more likely than not that the fair values of our reporting units were greater than their carrying amounts. After reaching this conclusion, no further testing was performed. The qualitative factors we considered included, but were not limited to, general economic conditions, our outlook in the rental laser service market, and our recent and forecasted financial performance. Many of the factors used in assessing fair value are outside the control of management, and these assumptions and estimates can change in future periods.
	Impairment of Long-Lived Assets
	Long-lived assets, such as property and equipment and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management's best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. To date, the Company has not recognized any impairment of long-lived assets.
	Stock-Based Compensation
	The Company accounts for equity based compensation under the provisions of ASC No. 718, "Compensation, Stock Compensation" ("ASC 718"). ASC 718 requires the recognition of the fair value of equity-based compensation in operations. The fair value of the Company's stock option awards are estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions and elections including expected stock price volatility and the estimated life of each award. In addition, the calculation of equity-based compensation costs requires that the Company estimate the number of awards that will be forfeited during the vesting period. The fair value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.
	No options were granted during the fiscal years ended September 30, 2013 and 2014.
	As of September 30, 2014, there was approximately $2,970 of total unrecognized compensation cost, net of estimated expected forfeitures, related to employee and director stock option compensation arrangements. This unrecognized cost is expected to be recognized on a straight-line basis over the next two years, which is consistent with the vesting period.
	The following table summarizes stock-based compensation expense related to employee stock options under ASC No. 718 for the fiscal years ended September 30, 2014 and 2013, which was allocated as follows:
		Fiscal Years Ended September 30,
		2014			2013
	Stock-based compensation included in:
	Cost of revenues	$	1,000		$	1,000
	Selling, general, and administrative expenses		2,000			12,000
		$	3,000		$	13,000
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include inventory valuation, allowances for doubtful accounts and deferred income tax assets, recoverability of goodwill and long-lived assets, losses for contingencies and certain accrued liabilities, as well as the valuation of equity compensation.
	Fair Value of Financial Instruments
	The Company accounts for financial instruments under the guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, Fair Value Measurements, as well as certain related FASB staff positions.  This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:
	●   Level 1 – quoted market prices in active markets for identical assets or liabilities.
	●   Level 2 – inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	●   Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The Company's financial remaining instruments consisted primarily of (level 1) cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, capital leases and note payable. The carrying amounts of the Company's financial instruments generally approximate their fair values as of September 30, 2014 and 2013 due to the short term nature of these instruments.
	The Company did not have any level 2 or 3 instruments at September 30, 2014 and 2013.
	Per Share Information
	Basic per share information is computed based upon the weighted average number of common shares outstanding during the period. Diluted per share information consists of the weighted average number of common shares outstanding, plus the dilutive effects of options and warrants calculated using the treasury stock method. In loss periods, dilutive common equivalent shares are excluded as the effect would be anti-dilutive. During the years ended September 30, 2014 and 2013, outstanding options of 808,900 and 839,400, respectively, were excluded from the diluted net loss per share as the effects would have been anti-dilutive. In addition, the exercise prices of these options were in excess of the average closing price of the Company's common stock for the years ended September 30, 2014 and 2013.
	Revenue Recognition
	The Company's revenues include revenues from the sale of reusable and disposable Fibers, Needles, and Switch Tips, the sale and rental of Lasers and accessories, and service contracts for Lasers manufactured by the Company.
	The Company recognizes revenue from products sold once all of the following criteria for revenue recognition have been met: (i) persuasive evidence that an arrangement exists, (ii) the products have been shipped, (iii) the prices are fixed and determinable and not subject to refund or adjustment, and (iv) collection of the amounts due is reasonably assured. Sales tax collected from customers are not considered revenue and are included in accounts payable and accrued liabilities until remitted to the taxing authorities.
	Revenues from the sale of Fibers, Needles, and Switch Tips and lasers are recognized upon shipment and passage of title of the products, provided that all other revenue recognition criteria have been met. Generally, customers are required to insure the goods from the Company's place of business. Accordingly, the risk of loss transfers to the customer once the goods have been shipped from the Company's warehouse. The Company sells its products primarily through commission sales representatives in the United States and distributors in foreign countries. In cases where the Company utilizes distributors, it recognizes revenue upon shipment, provided that all other revenue recognition criteria have been met, and ownership risk has transferred. In general, the Company does not have any post shipment obligations such as installation or acceptance provisions. All domestic laser systems are sold with a one year warranty which includes parts and labor. All international lasers systems are sold with a one year parts only warranty. As each laser sale is recognized, a liability is accrued for estimated future warranty costs.
	The Company utilizes distributors for international sales only. All laser system sales are non-returnable. Our international distributors typically locate customers for lasers before ordering and in general do not maintain inventories. The Company's return policy for laser accessories, Fibers, Needles, and Switch Tips sold to distributors is as follows: (1) the Company will accept returns of any unopened, undamaged, standard catalogue items (except laser systems) within sixty (60) days of invoice date. Acceptable returned products will be subject to a 20% restocking fee, (2) a return authorization number is required for all returns, which can be obtained by contacting the Customer Service Department, and (3) should a product be found defective at the time of initial use, the Company will replace it free of charge.
	The Company offers service contracts on its lasers. These service contracts are offered at different pricing levels based on the level of coverage, which include periodic maintenance and different levels of parts and labor to be provided. Since the service contracts have a twelve-month term, the revenue of each service contract is deferred and recognized ratably over the term of the service contract.
	Trimedyne’s facility in California may rent its Lasers for a flat monthly charge for a period of years or on a month-to-month basis, or on a fee per case basis, sometimes with a minimum monthly rental fee. During the fiscal years ended September 30, 2014 and 2013, one Laser was being rented by Trimedyne’s facility in California on a month-to-month basis. For this laser, rental revenue was recorded ratably over the rental period. MST generally enters into rental service contracts with customers for a two year period which, unless cancelled, are renewed on an annual basis after the initial period. During the rental service contract period customers do not maintain possession of any rental equipment unless it is for the Company's convenience. Customers are billed on a fee per case basis for rentals, which includes the services of the laser operator and, in some cases, the use of a reusable or single use laser delivery device. Revenue from these rental service contracts is recognized as the cases are performed.
	Cost of Revenues
	Cost of revenues consists primarily of the cost of materials and allocations of direct and indirect labor and overhead costs. Items included within these costs include but are not limited to personnel costs, depreciation, amortization of intangibles and various overhead allocations for items such as rent, utilities, etc.
	Shipping and Handling Costs
	Costs incurred for shipping and handling are included in cost of equipment and services revenues at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.
	Product Warranty Costs
	The Company provides warranties for certain products and maintains warranty reserves for estimated product warranty costs at the time of sale. In estimating its future warranty obligations, the Company considers various relevant factors, including the Company's stated warranty policies and practices, the historical frequency of claims and the cost to replace or repair its products under warranty. The following table provides a summary of the activity related to the Company's accrued warranty expense:
		For The Years Ended September 30,
		2014			2013
	Balance at beginning of year	$	16,000		$	23,000
	Charges to costs and expenses		49,000			27,000
	Costs incurred		(38,000	)		(34,000	)
	Balance at end of year	$	27,000		$	16,000
	Research and Development Costs
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company's products have been expensed as incurred.
	Income Taxes
	The Company uses the asset and liability method which requires the recognition of deferred tax liabilities and assets for expected future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities. Management provides a valuation allowance for deferred tax assets when it is more likely than not that all or a portion of such assets will not be recoverable based on future operations.
Potential interest and penalties related to income tax matters are recognized in income tax expense. The Company believes they have appropriate support for the income tax positions taken and to be taken on future income tax returns.
Property and Equipment
Property and equipment is recorded at cost. Depreciation of property and equipment is calculated on a straight-line basis over the estimated useful lives of the assets ranging from three to ten years. Leasehold improvements are amortized on a straight-line basis over the lesser of the useful lives or the term of the lease. Depreciation expense for the years ended September 30, 2014 and 2013, was $218,000 and $241,000, respectively.
Segment Information
The Company reports information about operating segments, as well as disclosures about products and services, geographic areas and major customers (see Note 9). Operating segments are defined as revenue-producing components of the enterprise, which are generally used internally for evaluating segment performance.
Recently Issued Accounting Pronouncements
Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

3_Composition_Of_Certain_Balan

3. Composition Of Certain Balance Sheet Captions	12 Months Ended
	Sep. 30, 2014
Composition Of Certain Balance Sheet Captions
3. Composition Of Certain Balance Sheet Captions	Inventories consist of the following:
		As of September 30,
		2014			2013
	Raw materials	$	549,000		$	501,000
	Work-in-process		298,000			94,000
	Finished goods		734,000			606,000
		$	1,581,000		$	1,201,000
	For the fiscal years ended September 30, 2014 and 2013, the aggregate net realizable value of demonstration and evaluation lasers did not comprise a material amount in inventories.
	Other current assets consist of the following:
		As of September 30,
		2014			2013
	Royalty receivable	$	–		$	25,000
	Prepaid rent		13,000			13,000
	Prepaid insurance		55,000			68,000
	Short-term deposits		8,000			8,000
	Prepaid income tax		11,000			6,000
	Other		36,000			46,000
	Total other current assets	$	123,000		$	166,000
	Property and equipment, net consist of the following:
		As of September 30,
		2014			2013
	Furniture and equipment	$	3,474,000		$	3,434,000
	Leasehold improvements		57,000			45,000
	Other		316,000			317,000
			3,847,000			3,796,000
	Less accumulated depreciation and amortization		(3,212,000	)		(3,090,000	)
		$	635,000		$	706,000
	As of September 30, 2014, equipment purchased under capital leases had a cost of $119,000 and accumulated depreciation of $36,000. As of September 30, 2013, equipment purchased under capital leases had a cost of $264,000 and accumulated depreciation of $214,000.
	Accrued expenses consist of the following:
		As of September 30,
		2014			2013
	Accrued vacation	$	181,000		$	146,000
	Accrued salaries and wages		60,000			51,000
	Sales and use tax		58,000			52,000
	Accrued bonus		17,000			30,000
	Accrued compensation		–			55,000
	Customer deposits		190,000			2,000
	Commissions		19,000			23,000
	Medical device tax		83,000			39,000
	Other		20,000			18,000
	Total accrued expenses	$	628,000		$	416,000

4_Note_Payable_and_Capital_Lea

4. Note Payable and Capital Leases	12 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]
4. Note Payable and Capital Leases	Note Payable and Capital Lease Obligations
	Note payable and capital leases consist of the following at September 30, 2014 and 2013:
		2014			2013
	Capital lease agreement in connection with the purchasing of equipment bearing an effective interest rate of 8.41% per annum. The lease requires monthly payments of $3,766 through October 2016.	$	83,000			–
	Finance agreement issued in connection with the purchasing of insurance policies. The note bears interest at 3.35% per annum and require monthly principal and interest payments of $9,851 through March 2014.		–			49,000
	Finance agreement issued in connection with the purchasing of insurance policies. The note bears interest at 3.35% per annum and require monthly principal and interest payments of $5,693 through March 2015.		30,000			–
		$	113,000		$	49,000
	Less: current portion		(70,000	)		(49,000	)
		$	43,000		$	–
	The capital lease agreement noted above for the purchase of equipment is secured by the related equipment with original value of approximately $119,000.
	Minimum capital lease payments will be $45,000 in fiscal 2015 and 2016, which includes interest of approximately $5,000 and $2,000 respectively.

5_Income_Taxes

5. Income Taxes	12 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]
5. Income Taxes	The deferred income tax balances at September 30, 2014 and 2013, are comprised of the following:
		2014			2013
	Deferred income tax assets (liabilities):
	Net operating loss carry forwards	$	7,035,000		$	5,529,000
	Inventories		380,000			336,000
	Reserves and accruals		154,000			63,000
	Research and development credits		2,379,000			2,202,000
	Depreciation and amortization		(426,000	)		(87,000	)
	Other		90,000			90,000
	Valuation allowance		(9,612,000	)		(8,133,000	)
		$	–		$	–
	The valuation allowance for deferred tax assets increased approximately $1,479,000 during the year ended September 30, 2014 and decreased approximately $1,259,000 during the year ended September 30, 2013, primarily due to a portion of the Company's net operating loss carryforwards ("NOLS") for federal and state income tax reporting. For the years ended September 30, 2014 and 2013, the Company recorded a current provision for federal and state income taxes of $7,000 and $17,000, respectively. In addition, there was not a provision for deferred income taxes due to a full valuation allowance on the Company’s deferred tax assets for fiscal years ended September 30, 2014 and 2013.
	The Company's effective income tax rate differs from the statutory federal income tax rate as follows for the years ended September 30, 2014 and 2013:
		2014			2013
	Statutory federal income tax rate		34.00%			34.00%
	Increase (decrease) in tax rate resulting from:
	State tax benefit, net of federal benefit		2.20%			3.20%
	Other		2.10%			(4.2%	)
	Valuation Allowance		(40.2%	)		(28.1%	)
	Effective income tax rate		(1.9%	)		4.90%
	At September 30, 2014, the Company had NOL carry forwards for Federal and California income tax purposes, totaling approximately $20.3 million and $2.3 million, respectively. The NOL carryforwards include Federal and State R & D credits of $1.4 million and $1.5 million, respectively. At September 30, 2013, the Company had NOL carry forwards for Federal and California income tax purposes, totaling approximately $15.8 million and $2.5 million, respectively. Federal and California NOL's have begun to expire and fully expire in 2034. The Tax Reform Act of 1986 includes provisions which may limit the new operating loss carry forwards available for use in any given year if certain events occur, including significant changes in stock ownership. In addition, the Company has R & D credits that have begun to expire and fully expire in 2034 for federal tax purposes.
	The Company has identified the United States Federal tax returns as its "major" tax jurisdiction. The United States Federal return years 2011 through 2013 are still subject to tax examination by the United States Internal Revenue Service; however, we do not currently have any ongoing tax examinations.  The Company is subject to examination by various State agencies for the years ended 2010 through 2013 and currently does not have any ongoing tax examinations.

6_Commitments_And_Contingencie

6. Commitments And Contingencies	12 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
6. Commitments And Contingencies	Lease Commitments
	The Company has two non-cancelable operating leases, which include a lease for MST's facility in Dallas, Texas, which expires in August 31, 2016, for $3,375 per month, and a lease for the Company's corporate office and manufacturing facility in Irvine, California. The lease term is for 36 months with two increases over the term. The initial monthly amount of rent to be paid is $6,911 with the second month free, followed by an increase in monthly rent to $7,118 beginning month 13 and another increase beginning month 24 to $7,332, with the 25th month rent free.
	Future annual minimum lease payments under the above lease agreements at September 30, 2014, are as follows:
	Years ending
	September 30,
	2015	$	127,000
	2016		88,000
	Total	$	215,000
	Rent expense for the years ended September 30, 2014 and 2013 was approximately $150,000 and $255,000, respectively.
	Rent expense is recognized on a straight-line basis over the term of the lease. Therefore, rent expense on the leases does not correspond with the actual rent payments due. As of September 30, 2014 and 2013, this liability was $6,000 and $11,000, respectively.
	See Note 4 regarding capital leases.
	Settlement and OEM Agreement
	On August 24, 2005, we entered into a five year OEM agreement with Lumenis. Under the OEM agreement, Lumenis agreed to pay us a royalty of 7.5% of its worldwide sales of side firing and angled firing laser fibers, and Lumenis also agreed to purchase 100% of its needs for side firing laser fibers and 75% of its needs for angled firing laser fibers from us, subject to our laser fibers meeting certain performance standards and satisfactory completion of an audit of our manufacturing process and quality system. This Agreement expired on August 23, 2010.
	Under the license agreement dated as of August 23, 2010, Lumenis extended the 7.5% royalty payment period to July 21, 2014.
	During the fiscal years ended September 30, 2014 and 2013, the Company received $78,000 and $98,000, respectively, under the license agreement, which was included in other income.
	Sale of Patents
	In January 2012, the Company entered into an agreement for the sale of certain patents held by the Company to a third party. Under the terms of the agreement the Company received a non-refundable payment of $200,000, and we received a non-exclusive, royalty free license to the patents. If the third party entered into any litigation regarding any infringement of these patents, the Company would receive 35% of all net (after legal fees) proceeds received by the third party, up to $6 million, less the initial $200,000 payment and 50% of net proceeds over $6 million, if any. The third party filed a lawsuit against a large foreign company that the third party believed was infringing some of the patents sold to the third party by Trimedyne. During the fiscal year ended September 30, 2014 and 2013, the Company received $4,000 and $433,000, respectively, as a result of the above sale and agreement.
	Product Liability
	The Company is subject to various claims and actions which arise in the ordinary course of business. The litigation process is inherently uncertain, and it is possible that the resolution of any of the Company's existing and future litigation may adversely affect the Company. Management is unaware of any matters which are not reflected in the consolidated financial statements that may have material impact on the Company's financial position, results of operations or cash flows.
	Guarantees and Indemnities
	The Company has made certain indemnities and guarantees, under which it may be required to make payments to a guaranteed or indemnified party. The Company indemnifies its directors, officers, employees and agents to the maximum extent permitted under the laws of the State of California. In connection with its facility leases, the Company has indemnified its lessors for certain claims arising from the use of the facilities. The duration of the guarantees and indemnities varies, and in many cases is indefinite. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheet.
	Risks and Uncertainties
	The Centers for Medicare and Medicaid Services (CMS), the agency of the U.S. Government that administers the Medicare Program, does not reimburse for thermal intradiscal procedures to treat spinal discs including the use of the Company's pulsed Holmium Lasers. Since most people suffering from a herniated or ruptured spinal disc are below Medicare age, we do not believe CMS's decision will have an adverse impact on our business.

7_Stockholders_Equity

7. Stockholders Equity	12 Months Ended
	Sep. 30, 2014
Equity [Abstract]
7. Stockholders Equity	Stock Options
	The Company has adopted stock option plans that authorize the granting of options to key employees, directors, and consultants to purchase unissued common stock subject to certain conditions, such as continued employment. Options are generally granted at the fair market value of the Company's common stock at the date of grant, become exercisable over a period of five years from the date of grant, and generally expire in six or ten years specific to their respective plan. Forfeitures of stock options are returned to the Company and become available for grant under the respective plan. Upon exercise the Company issues new shares of common stock.
	No options were granted during the fiscal years ended September 30, 2013 and 2014.
	Stock Options Outstanding:
							Weighted-
							Average
					Weighted-		Remaining
					Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(Years)		Value
	Options outstanding at September 30, 2012		1,003,650		$	0.23
	Options granted		–			–
	Options exercised		–			–
	Options forfeited		(164,250	)		0.34
	Options outstanding at September 30, 2013		839,400		$	0.2
	Options granted		–			–
	Options exercised		–			–
	Options forfeited		(30,500	)		0.17
	Options outstanding at September 30, 2014		808,900		$	0.2		3.4	$	5,500
	Options exercisable at September 30, 2014		754,500		$	0.21		3.2	$	5,500
	On August 13, 2003 the Company's Board of Directors adopted the 2003 Non-statutory Stock Option Plan ("2003 Plan") for issuance of stock options to employees and others. Under the 2003 Plan, the Company reserved two million shares for issuance. As of September 30, 2014 and 2013, 1,191,100 and 1,160,600 options were available for issuance under the 2003 Plan, respectively.
	The following table summarizes information concerning outstanding and exercisable options at September 30, 2014:
		OPTIONS OUTSTANDING							OPTIONS EXERCISABLE
	Range of	Outstanding as of			Weighted-Average Remaining		Weighted-Average		Exercisable as of 9/30/2014		Weighted-Average
	Exercise Prices	9/30/14			Contractual Life (years)		Exercise Price				Exercise Price
	$0.05 - 0.13		265,000			2.8	$	0.1		265,000	$	0.1
	$0.14 - 0.50		424,000			4.5	$	0.17		369,900	$	0.17
	$0.51 - 0.64		119,900			0.7	$	0.58		119,900	$	0.58
			808,900			3.4	$	0.2		754,500	$	0.21
	There were no options granted or exercised during the fiscal years ended September 30, 2014 and 2013.

8_Employee_Benefit_Plan

8. Employee Benefit Plan	12 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]
8. Employee Benefit Plan	The Company has a 401(k) retirement savings plan (the "Retirement Plan"), which was merged into the ADP TotalSource Multiple Employer Plan as of March 2012. Under the terms of the Retirement Plan, employees may, subject to certain limitations, contribute up to 15% of their total compensation. The Company contributes an additional $0.50 for each dollar of employee contributions up to 4% of eligible employee compensation. Employees become vested in the Company's contribution at 20% per year over five years. The Company's annual contributions to the Retirement Plan for the fiscal years ended September 30, 2014 and 2013 totaled $17,000 and $20,000, respectively.

9_Segment_Information

9. Segment Information	12 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]
9. Segment Information	The Company's segments consist of individual companies managed separately with each manager reporting to the Chief Executive Officer. Revenues, and operating or segment profit, are reflected net of inter-segment sales and profits. Segment profit is comprised of net sales less operating expenses. Other income and expense and income taxes are not allocated and reported by segment since they are excluded from the measure of segment performance reviewed by management.
		For the year ended September 30, 2014									For the year ended September 30, 2013
		Product			Service and Rental			Total			Product			Service and Rental		Total
	Revenues	$	2,950,000		$	2,511,000		$	5,461,000		$	3,130,000		$	2,859,000	$	5,989,000
	Cost of sales		1,776,000			1,738,000			3,514,000			1,721,000			1,900,000		3,621,000
	Gross profit		1,174,000			773,000			1,947,000			1,409,000			959,000		2,368,000
	Expenses:
	Selling, general and administrative		1,335,000			607,000			1,942,000			1,647,000			682,000		2,329,000
	Research and development		471,000			–			471,000			407,000			–		407,000
	Income (loss) from operations	$	(632,000	)	$	166,000			(466,000	)	$	(645,000	)	$	277,000		(368,000	)
	Other income (expense):
	Royalty income		78,000			98,000
	Interest expense		(10,000	)		(2,000	)
	Net gain on disposal of assets		–			8,000
	Settlements and other		24,000			610,000
	Income (loss) before provision for income taxes		(374,000	)		346,000
	Provision for income taxes		7,000			17,000
	Net income ( loss)	$	(381,000	)	$	329,000
	Sales in foreign countries in fiscal 2014 and 2013 accounted for approximately 22.7% and 19.0%, respectively, of the Company's total sales. The breakdown of foreign sales by geographic region is as follows:
		2014			2013
	Asia	$	969,000		$	551,000
	Europe		70,000			304,000
	Latin America		131,000			245,000
	Middle East		1,000			3,000
	Australia		65,000			31,000
	Other		4,000			2,000
		$	1,240,000		$	1,136,000
	Sales and gross profit to customers by similar products and services for the fiscal years ended September 30, 2014 and 2013 were as follows:
		2014			2013
	By similar products and services:
	Sales
	Products:
	Lasers and accessories	$	759,000		$	504,000
	Fibers, Needles and SwitchTips		2,191,000			2,626,000
	Service and rental		2,511,000			2,859,000
	Total	$	5,461,000		$	5,989,000
	Gross profit
	Products:
	Lasers and accessories	$	143,000		$	79,000
	Fibers, Needles and Switch Tips		1,031,000			1,330,000
	Service and rental		773,000			959,000
	Total	$	1,947,000		$	2,368,000
	The Company had one laser located in Canada at September 30, 2014. Total segment assets for the Products segment were $3,070,000 and Service and Rental were $1,616,000 at September 30, 2014. Total segment assets differ from total assets on a consolidated basis as a result of unallocated corporate assets primarily comprised of immaterial amounts of property and equipment, etc. During the year ended September 30, 2014 and 2013, additions of property and equipment to the Service and Rental segment were $4,000 and $52,000, respectively.

10_Related_Party_Transactions

10. Related Party Transactions	12 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]
10. Related Party Transactions	The Company has an agreement with its CEO to share an employee with Cardiomax, Inc., a company owned by the CEO. Cardiomax, Inc. is billed for the reimbursement of time that the employee is paid by the Company.
	During the fiscal year ended September 30, 2014, the amount received for reimbursement under the above agreement was approximately $6,700.
	On September 11, 2014, the Company purchased a 3,000,000 shares of common stock for $30,000, equal to a 30% interest, from Gastrodyne, Inc., a company 70% owned by The Marvin Loeb Irrevocable Trust.

11_Subsequent_Events

11. Subsequent Events	12 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]
11. Subsequent Events	On December 1, 2014, the Company financed an insurance policy with a note for $21,607. The note bears interest at 4.75% per annum and required monthly principal and interest payments of $2,011 through November 2015.

Recovered_Sheet1

2. Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of Trimedyne, Inc., its wholly owned subsidiary, MST, Inc., and its 90% owned and inactive subsidiary, Cardiodyne, Inc. ("Cardiodyne").  All intercompany accounts and transactions have been eliminated in consolidation.
Concentration of Credit Risk and Customer Concentration	Concentration of Credit Risk and Customer Concentration
	The Company generates revenues principally from sales of products in the medical field. As a result, the Company's trade accounts receivable are concentrated primarily in this industry. The Company performs limited credit evaluations of its customers and generally does not require collateral. The Company maintains reserves for potential credit losses. The Company considers the following factors when determining if collection of a fee is reasonably assured: customer credit-worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment terms. In some cases in regards to new customers, management requires payment in full or letters of credit before goods are shipped or services are performed. If these factors do not indicate collection is reasonably assured, revenue is deferred until collection becomes reasonably assured, which is generally upon receipt of cash. During fiscal 2014 and 2013, credit losses were not significant.
	During the current fiscal year ended 2014, the Company had sales to two customers, which represented approximately 30% of product sales. During the fiscal year ended 2013, the Company had sales to one customer, which represented approximately 11% of product sales. During the fiscal years ended September 30, 2014 and 2013, there were no concentrations of service and rental sales.
	If the relationship between the Company and these customers was altered, the futures results of operations and financial condition could be significantly affected. Additionally, during fiscal 2014 and 2013, export sales approximated 23.0% and 19.0% of sales, respectively.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with insignificant interest rate risk and original maturities of three months or less from the date of purchase to be cash equivalents. The carrying amounts of cash and cash equivalents approximate their fair values.
	At September 30, 2014, the Company had cash balances in excess of federally insured limits of $250,000 in the amount of $972,000.
Inventories	Inventories
	Inventories consist of raw materials and component parts, work-in-process and finished goods consisting of lasers and dispensing systems. Inventories are recorded at the lower of cost or market, cost being determined principally by use of the average-cost method, which approximates the first-in, first-out method. Cost is determined at the actual cost for raw materials, and at production cost (materials, labor and indirect manufacturing overhead) for work-in-process and finished goods.
	Laser units located at medical facilities for sales evaluation and demonstration purposes or those units used for development and medical training are included in inventory since the lasers will ultimately be sold. These units are written down to reflect their net realizable values. Write-downs are considered permanent reductions at cost basis of the related inventories.
Goodwill	Goodwill
	The Company accounts for goodwill and acquired intangible assets in accordance with Accounting Standards Codification (“ASC”) ASC No. 350 "Intangible and Other", whereby goodwill is not amortized, and is tested for impairment at the reporting unit level annually during the fourth quarter and in interim periods if certain events occur indicating that the carrying value of goodwill may be impaired. A reporting unit is an operating segment for which discrete financial information is available and is regularly reviewed by management. The Company has one reporting unit, our service and rental group, to which goodwill is assigned.
	ASC No. 350 requires a two-step approach to test goodwill for impairment for each reporting unit. The first step tests for impairment by applying fair value-based tests to a reporting unit. The second step, if deemed necessary, measures the impairment by applying fair value-based tests to specific assets and liabilities within the reporting unit. Application of the goodwill impairment tests require judgment, including identification of reporting units, assignment of assets and liabilities to each reporting unit, assignment of goodwill to each reporting unit, and determination of the fair value of each reporting unit. The determination of fair value for a reporting unit could be materially affected by changes in these estimates and assumptions.
	We concluded that it was more likely than not that the fair values of our reporting units were greater than their carrying amounts. After reaching this conclusion, no further testing was performed. The qualitative factors we considered included, but were not limited to, general economic conditions, our outlook in the rental laser service market, and our recent and forecasted financial performance. Many of the factors used in assessing fair value are outside the control of management, and these assumptions and estimates can change in future periods.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
	Long-lived assets, such as property and equipment and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of the asset is measured by comparison of its carrying amount to undiscounted future net cash flows the asset is expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the asset exceeds its fair market value. Estimates of expected future cash flows represent management's best estimate based on currently available information and reasonable and supportable assumptions. Any impairment recognized is permanent and may not be restored. To date, the Company has not recognized any impairment of long-lived assets.
Stock-Based Compensation	Stock-Based Compensation
	The Company accounts for equity based compensation under the provisions of ASC No. 718, "Compensation, Stock Compensation" ("ASC 718"). ASC 718 requires the recognition of the fair value of equity-based compensation in operations. The fair value of the Company's stock option awards are estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions and elections including expected stock price volatility and the estimated life of each award. In addition, the calculation of equity-based compensation costs requires that the Company estimate the number of awards that will be forfeited during the vesting period. The fair value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.
	No options were granted during the fiscal years ended September 30, 2013 and 2014.
	As of September 30, 2014, there was approximately $2,970 of total unrecognized compensation cost, net of estimated expected forfeitures, related to employee and director stock option compensation arrangements. This unrecognized cost is expected to be recognized on a straight-line basis over the next two years, which is consistent with the vesting period.
	The following table summarizes stock-based compensation expense related to employee stock options under ASC No. 718 for the fiscal years ended September 30, 2014 and 2013, which was allocated as follows:
		Fiscal Years Ended September 30,
		2014			2013
	Stock-based compensation included in:
	Cost of revenues	$	1,000		$	1,000
	Selling, general, and administrative expenses		2,000			12,000
		$	3,000		$	13,000
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include inventory valuation, allowances for doubtful accounts and deferred income tax assets, recoverability of goodwill and long-lived assets, losses for contingencies and certain accrued liabilities, as well as the valuation of equity compensation.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The Company accounts for financial instruments under the guidance under Financial Accounting Standards Board (“FASB”) ASC 820-10, Fair Value Measurements, as well as certain related FASB staff positions.  This guidance defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact business and considers assumptions that marketplace participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance.
	The guidance also establishes a fair value hierarchy for measurements of fair value as follows:
	●   Level 1 – quoted market prices in active markets for identical assets or liabilities.
	●   Level 2 – inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	●   Level 3 – unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The Company's financial remaining instruments consisted primarily of (level 1) cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, capital leases and note payable. The carrying amounts of the Company's financial instruments generally approximate their fair values as of September 30, 2014 and 2013 due to the short term nature of these instruments.
	The Company did not have any level 2 or 3 instruments at September 30, 2014 and 2013.
Per Share Information	Per Share Information
	Basic per share information is computed based upon the weighted average number of common shares outstanding during the period. Diluted per share information consists of the weighted average number of common shares outstanding, plus the dilutive effects of options and warrants calculated using the treasury stock method. In loss periods, dilutive common equivalent shares are excluded as the effect would be anti-dilutive. During the years ended September 30, 2014 and 2013, outstanding options of 808,900 and 839,400, respectively, were excluded from the diluted net loss per share as the effects would have been anti-dilutive. In addition, the exercise prices of these options were in excess of the average closing price of the Company's common stock for the years ended September 30, 2014 and 2013.
Revenue Recognition	Revenue Recognition
	The Company's revenues include revenues from the sale of reusable and disposable Fibers, Needles, and Switch Tips, the sale and rental of Lasers and accessories, and service contracts for Lasers manufactured by the Company.
	The Company recognizes revenue from products sold once all of the following criteria for revenue recognition have been met: (i) persuasive evidence that an arrangement exists, (ii) the products have been shipped, (iii) the prices are fixed and determinable and not subject to refund or adjustment, and (iv) collection of the amounts due is reasonably assured. Sales tax collected from customers are not considered revenue and are included in accounts payable and accrued liabilities until remitted to the taxing authorities.
	Revenues from the sale of Fibers, Needles, and Switch Tips and lasers are recognized upon shipment and passage of title of the products, provided that all other revenue recognition criteria have been met. Generally, customers are required to insure the goods from the Company's place of business. Accordingly, the risk of loss transfers to the customer once the goods have been shipped from the Company's warehouse. The Company sells its products primarily through commission sales representatives in the United States and distributors in foreign countries. In cases where the Company utilizes distributors, it recognizes revenue upon shipment, provided that all other revenue recognition criteria have been met, and ownership risk has transferred. In general, the Company does not have any post shipment obligations such as installation or acceptance provisions. All domestic laser systems are sold with a one year warranty which includes parts and labor. All international lasers systems are sold with a one year parts only warranty. As each laser sale is recognized, a liability is accrued for estimated future warranty costs.
	The Company utilizes distributors for international sales only. All laser system sales are non-returnable. Our international distributors typically locate customers for lasers before ordering and in general do not maintain inventories. The Company's return policy for laser accessories, Fibers, Needles, and Switch Tips sold to distributors is as follows: (1) the Company will accept returns of any unopened, undamaged, standard catalogue items (except laser systems) within sixty (60) days of invoice date. Acceptable returned products will be subject to a 20% restocking fee, (2) a return authorization number is required for all returns, which can be obtained by contacting the Customer Service Department, and (3) should a product be found defective at the time of initial use, the Company will replace it free of charge.
	The Company offers service contracts on its lasers. These service contracts are offered at different pricing levels based on the level of coverage, which include periodic maintenance and different levels of parts and labor to be provided. Since the service contracts have a twelve-month term, the revenue of each service contract is deferred and recognized ratably over the term of the service contract.
	Trimedyne’s facility in California may rent its Lasers for a flat monthly charge for a period of years or on a month-to-month basis, or on a fee per case basis, sometimes with a minimum monthly rental fee. During the fiscal years ended September 30, 2014 and 2013, one Laser was being rented by Trimedyne’s facility in California on a month-to-month basis. For this laser, rental revenue was recorded ratably over the rental period. MST generally enters into rental service contracts with customers for a two year period which, unless cancelled, are renewed on an annual basis after the initial period. During the rental service contract period customers do not maintain possession of any rental equipment unless it is for the Company's convenience. Customers are billed on a fee per case basis for rentals, which includes the services of the laser operator and, in some cases, the use of a reusable or single use laser delivery device. Revenue from these rental service contracts is recognized as the cases are performed.
Cost of Revenues	Cost of Revenues
	Cost of revenues consists primarily of the cost of materials and allocations of direct and indirect labor and overhead costs. Items included within these costs include but are not limited to personnel costs, depreciation, amortization of intangibles and various overhead allocations for items such as rent, utilities, etc.
Shipping and Handling Costs	Shipping and Handling Costs
	Costs incurred for shipping and handling are included in cost of equipment and services revenues at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.
Product Warranty Costs	Product Warranty Costs
	The Company provides warranties for certain products and maintains warranty reserves for estimated product warranty costs at the time of sale. In estimating its future warranty obligations, the Company considers various relevant factors, including the Company's stated warranty policies and practices, the historical frequency of claims and the cost to replace or repair its products under warranty. The following table provides a summary of the activity related to the Company's accrued warranty expense:
		For The Years Ended September 30,
		2014			2013
	Balance at beginning of year	$	16,000		$	23,000
	Charges to costs and expenses		49,000			27,000
	Costs incurred		(38,000	)		(34,000	)
	Balance at end of year	$	27,000		$	16,000
Research and Development Costs	Research and Development Costs
	All research and development costs, including licensing costs, are charged to expense as incurred. In accordance with this policy, all costs associated with the design, development and testing of the Company's products have been expensed as incurred.
Income Taxes	Income Taxes
	The Company uses the asset and liability method which requires the recognition of deferred tax liabilities and assets for expected future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities. Management provides a valuation allowance for deferred tax assets when it is more likely than not that all or a portion of such assets will not be recoverable based on future operations.
	Potential interest and penalties related to income tax matters are recognized in income tax expense. The Company believes they have appropriate support for the income tax positions taken and to be taken on future income tax returns.
Property and Equipment	Property and Equipment
	Property and equipment is recorded at cost. Depreciation of property and equipment is calculated on a straight-line basis over the estimated useful lives of the assets ranging from three to ten years. Leasehold improvements are amortized on a straight-line basis over the lesser of the useful lives or the term of the lease. Depreciation expense for the years ended September 30, 2014 and 2013, was $218,000 and $241,000, respectively.
Segment Information	Segment Information
	The Company reports information about operating segments, as well as disclosures about products and services, geographic areas and major customers (see Note 9). Operating segments are defined as revenue-producing components of the enterprise, which are generally used internally for evaluating segment performance.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements
	Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

2_Summary_of_Significant_Accou1

2. Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2014
Summary Of Significant Accounting Policies Tables
Allocated Stock-based compensation expense		Fiscal Years Ended September 30,
		2014			2013
	Stock-based compensation included in:
	Cost of revenues	$	1,000		$	1,000
	Selling, general, and administrative expenses		2,000			12,000
		$	3,000		$	13,000
Summary of accrued warranty expense		For The Years Ended September 30,
		2014			2013
	Balance at beginning of year	$	16,000		$	23,000
	Charges to costs and expenses		49,000			27,000
	Costs incurred		(38,000	)		(34,000	)
	Balance at end of year	$	27,000		$	16,000

Recovered_Sheet2

3. Composition of Certain Balance Sheet Captions (Tables)	12 Months Ended
	Sep. 30, 2014
Composition Of Certain Balance Sheet Captions
Inventories		As of September 30,
		2014			2013
	Raw materials	$	549,000		$	501,000
	Work-in-process		298,000			94,000
	Finished goods		734,000			606,000
		$	1,581,000		$	1,201,000
Other current assets		As of September 30,
		2014			2013
	Royalty receivable	$	–		$	25,000
	Prepaid rent		13,000			13,000
	Prepaid insurance		55,000			68,000
	Short-term deposits		8,000			8,000
	Prepaid income tax		11,000			6,000
	Other		36,000			46,000
	Total other current assets	$	123,000		$	166,000
Property and equipment		As of September 30,
		2014			2013
	Furniture and equipment	$	3,474,000		$	3,434,000
	Leasehold improvements		57,000			45,000
	Other		316,000			317,000
			3,847,000			3,796,000
	Less accumulated depreciation and amortization		(3,212,000	)		(3,090,000	)
		$	635,000		$	706,000
Accrued expenses		As of September 30,
		2014			2013
	Accrued vacation	$	181,000		$	146,000
	Accrued salaries and wages		60,000			51,000
	Sales and use tax		58,000			52,000
	Accrued bonus		17,000			30,000
	Accrued compensation		–			55,000
	Customer deposits		190,000			2,000
	Commissions		19,000			23,000
	Medical device tax		83,000			39,000
	Other		20,000			18,000
	Total accrued expenses	$	628,000		$	416,000

4_Note_Payable_and_Capital_Lea1

4. Note Payable and Capital Leases (Tables)	12 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]
Schedule of notes payable and capital lease obligations		2014			2013
	Capital lease agreement in connection with the purchasing of equipment bearing an effective interest rate of 8.41% per annum. The lease requires monthly payments of $3,766 through October 2016.	$	83,000			–
	Finance agreement issued in connection with the purchasing of insurance policies. The note bears interest at 3.35% per annum and require monthly principal and interest payments of $9,851 through March 2014.		–			49,000
	Finance agreement issued in connection with the purchasing of insurance policies. The note bears interest at 3.35% per annum and require monthly principal and interest payments of $5,693 through March 2015.		30,000			–
		$	113,000		$	49,000
	Less: current portion		(70,000	)		(49,000	)
		$	43,000		$	–

5_Income_Taxes_Tables

5. Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities		2014			2013
	Deferred income tax assets (liabilities):
	Net operating loss carry forwards	$	7,035,000		$	5,529,000
	Inventories		380,000			336,000
	Reserves and accruals		154,000			63,000
	Research and development credits		2,379,000			2,202,000
	Depreciation and amortization		(426,000	)		(87,000	)
	Other		90,000			90,000
	Valuation allowance		(9,612,000	)		(8,133,000	)
		$	–		$	–
Schedule of Effective Income Tax Rate Reconciliation		2014			2013
	Statutory federal income tax rate		34.00%			34.00%
	Increase (decrease) in tax rate resulting from:
	State tax benefit, net of federal benefit		2.20%			3.20%
	Other		2.10%			(4.2%	)
	Valuation Allowance		(40.2%	)		(28.1%	)
	Effective income tax rate		(1.9%	)		4.90%

6_Commitments_And_Contingencie1

6. Commitments And Contingencies (Tables)	12 Months Ended
	Sep. 30, 2014
Commitments And Contingencies Tables
Future annual minimum lease payments	Years ending
	September 30,
	2015	$	127,000
	2016		88,000
	Total	$	215,000

7_Stockholders_Equity_Tables

7. Stockholders Equity (Tables)	12 Months Ended
	Sep. 30, 2014
Equity [Abstract]
Stock Options Outstanding							Weighted-
							Average
					Weighted-		Remaining
					Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(Years)		Value
	Options outstanding at September 30, 2012		1,003,650		$	0.23
	Options granted		–			–
	Options exercised		–			–
	Options forfeited		(164,250	)		0.34
	Options outstanding at September 30, 2013		839,400		$	0.2
	Options granted		–			–
	Options exercised		–			–
	Options forfeited		(30,500	)		0.17
	Options outstanding at September 30, 2014		808,900		$	0.2		3.4	$	5,500
	Options exercisable at September 30, 2014		754,500		$	0.21		3.2	$	5,500
Options outstanding and exercisable		OPTIONS OUTSTANDING							OPTIONS EXERCISABLE
	Range of	Outstanding as of			Weighted-Average Remaining		Weighted-Average		Exercisable as of 9/30/2014		Weighted-Average
	Exercise Prices	9/30/14			Contractual Life (years)		Exercise Price				Exercise Price
	$0.05 - 0.13		265,000			2.8	$	0.1		265,000	$	0.1
	$0.14 - 0.50		424,000			4.5	$	0.17		369,900	$	0.17
	$0.51 - 0.64		119,900			0.7	$	0.58		119,900	$	0.58
			808,900			3.4	$	0.2		754,500	$	0.21

9_Segment_Information_Tables

9. Segment Information (Tables)	12 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]
Segment Reporting by operating activities		For the year ended September 30, 2014									For the year ended September 30, 2013
		Product			Service and Rental			Total			Product			Service and Rental		Total
	Revenues	$	2,950,000		$	2,511,000		$	5,461,000		$	3,130,000		$	2,859,000	$	5,989,000
	Cost of sales		1,776,000			1,738,000			3,514,000			1,721,000			1,900,000		3,621,000
	Gross profit		1,174,000			773,000			1,947,000			1,409,000			959,000		2,368,000
	Expenses:
	Selling, general and administrative		1,335,000			607,000			1,942,000			1,647,000			682,000		2,329,000
	Research and development		471,000			–			471,000			407,000			–		407,000
	Income (loss) from operations	$	(632,000	)	$	166,000			(466,000	)	$	(645,000	)	$	277,000		(368,000	)
	Other income (expense):
	Royalty income		78,000			98,000
	Interest expense		(10,000	)		(2,000	)
	Net gain on disposal of assets		–			8,000
	Settlements and other		24,000			610,000
	Income (loss) before provision for income taxes		(374,000	)		346,000
	Provision for income taxes		7,000			17,000
	Net income ( loss)	$	(381,000	)	$	329,000
Sales breakdown by geographic region		2014			2013
	Asia	$	969,000		$	551,000
	Europe		70,000			304,000
	Latin America		131,000			245,000
	Middle East		1,000			3,000
	Australia		65,000			31,000
	Other		4,000			2,000
		$	1,240,000		$	1,136,000
Sales and gross profit to customers by similar products and services		2014			2013
	By similar products and services:
	Sales
	Products:
	Lasers and accessories	$	759,000		$	504,000
	Fibers, Needles and SwitchTips		2,191,000			2,626,000
	Service and rental		2,511,000			2,859,000
	Total	$	5,461,000		$	5,989,000
	Gross profit
	Products:
	Lasers and accessories	$	143,000		$	79,000
	Fibers, Needles and Switch Tips		1,031,000			1,330,000
	Service and rental		773,000			959,000
	Total	$	1,947,000		$	2,368,000

1_Organization_and_Business_De

1. Organization and Business (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Organization And Business Details Narrative
Working capital	$2,406,000	$2,711,000
Increase in cash	-280,000	1,100,000
Cash	$1,292,000	$1,572,000	$472,000

2_Summary_of_Significant_Accou2

2. Summary of Significant Accounting Policies (Details - Allocated Stock-Based Compensation) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Stock based compensation	$3,000	$13,000
Cost of Revenues [Member]
Stock based compensation	1,000	1,000
Selling, General, and Administrative Expenses [Member]
Stock based compensation	$2,000	$12,000

2_Summary_of_Significant_Accou3

2. Summary of Significant Accounting Policies (Details - Product Warranty Costs) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Accounting Policies [Abstract]
Balance at beginning of year	$16,000	$23,000
Charges to costs and expenses	49,000	27,000
Costs incurred	-38,000	-34,000
Balance at end of year	$27,000	$16,000

2_Summary_of_Significant_Accou4

2. Summary of Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash, FDIC Insured Amount	$250,000
Amount above federally insured limit	972,000
Unrecognized compensation cost	2,970
Unrecognized compensation cost, period for recognition	2 years
Outstanding options excluded from the diluted net loss per share	808,900	839,400
Depreciation expense	$218,000	$241,000
Sales Revenue, Goods, Net [Member] | Two Customers [Member]
Concentration percentage	30.00%
Sales Revenue, Goods, Net [Member] | One Customer [Member]
Concentration percentage		11.00%
Sales Revenue, Goods, Net [Member] | Exported Sales [Member]
Concentration percentage	23.00%	19.00%

3_Composition_Of_Certain_Balan1

3. Composition Of Certain Balance Sheet Captions (Details-Inventories) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Inventories, net of reserves, consist of the following
Raw materials	$549,000	$501,000
Work-in-process	298,000	94,000
Finished goods	734,000	606,000
Total Inventory	$1,581,000	$1,201,000

3_Composition_Of_Certain_Balan2

3. Composition Of Certain Balance Sheet Captions (Details-Other Current Assets) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Other current assets consist of the following
Royalty receivable	$0	$25,000
Prepaid rent	13,000	13,000
Prepaid insurance	55,000	68,000
Short-term deposits	8,000	8,000
Prepaid income tax	11,000	6,000
Other	36,000	46,000
Total other current assets	$123,000	$166,000

3_Composition_Of_Certain_Balan3

3. Composition Of Certain Balance Sheet Captions (Details-Property and Equipment) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Property and equipment consist of the following
Furniture and equipment	$3,474,000	$3,434,000
Leasehold improvements	57,000	45,000
Other	316,000	317,000
Property plant and equipment, gross	3,847,000	3,796,000
Less accumulated depreciation and amortization	-3,212,000	-3,090,000
Total property and equipment, net	$635,000	$706,000

3_Composition_Of_Certain_Balan4

3. Composition Of Certain Balance Sheet Captions (Details-Accrued Expenses) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Accrued expenses consist of the following
Accrued vacation	$181,000	$146,000
Accrued salaries and wages	60,000	51,000
Sales and use tax	58,000	52,000
Accrued bonus	17,000	30,000
Accrued compensation	0	55,000
Customer deposits	190,000	2,000
Commissions	19,000	23,000
Medical device tax	83,000	39,000
Other	20,000	18,000
Total accrued expenses	$628,000	$416,000

Recovered_Sheet3

3. Composition of Certain Balance Sheet Captions (Details Narrative) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Composition Of Certain Balance Sheet Captions
Capital leased equipment, cost	$119,000	$264,000
Capital leased equipment, accumulated depreciation	$36,000	$214,000

4_Note_Payable_and_Capital_Lea2

4. Note Payable and Capital Leases (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Gross Capital Lease and Finance Agreements Issued	$113,000	$49,000
Less: current portion	-70,000	-49,000
Total portion long-term	43,000	0
Capital Lease 1 [Member]
Gross Capital Lease and Finance Agreements Issued	83,000	0
Effective interest rate	8.41%
Maturity date	31-Oct-16
Finance Agreement 1 [Member]
Gross Capital Lease and Finance Agreements Issued	0	49,000
Effective interest rate	3.35%
Maturity date	31-Mar-14
Finance Agreement 2 [Member]
Gross Capital Lease and Finance Agreements Issued	$30,000	$0
Effective interest rate	3.35%
Maturity date	31-Mar-15

4_Note_Payable_and_Capital_Lea3

4. Note Payable and Capital Leases (Details Narrative) (USD $)	Sep. 30, 2014
Debt Disclosure [Abstract]
Minimum capital lease payment fiscal 2015	$45,000
Minimum capital lease payment fiscal 2016	$45,000

5_Income_Taxes_DetailsDeferred

5. Income Taxes (Details-Deferred Income Taxes) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Deferred income tax assets (liabilities):
Net operating loss carry forwards	$7,035,000	$5,529,000
Inventories	380,000	336,000
Reserves and accruals	154,000	63,000
Research and development credits	2,379,000	2,202,000
Depreciation and amortization	-426,000	-87,000
Other	90,000	90,000
Valuation allowance	-9,612,000	-8,133,000
Total Deferred income tax assets (liabilities)	$0	$0

5_Income_Taxes_DetailsEffectiv

5. Income Taxes (Details-Effective Tax Rate)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	34.00%	34.00%
Increase (decrease) in tax rate resulting from:
State tax benefit, net of federal benefit	2.20%	3.20%
Other	2.10%	-4.20%
Valuation Allowance	-40.20%	-28.10%
Effective income tax rate	-1.90%	4.90%

5_Income_Taxes_Details_Narrati

5. Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Change in valuation allowance	$1,479,000	($1,259,000)
Current provision for state income taxes	7,000	17,000
Research and development tax credits	1,400,000	1,500,000
Federal [Member]
Net operating loss carryforwards	20,300,000	15,800,000
Carryforward expiration date	31-Dec-34
State [Member]
Net operating loss carryforwards	$2,300,000	$2,500,000
Carryforward expiration date	31-Dec-34

Recovered_Sheet4

6. Commitments and Contingenciees (Details-Minimum Lease Payments) (USD $)	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
2015	$127,000
2016	88,000
Total	$215,000

Recovered_Sheet5

6. Commitments and Contingencies (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$150,000	$255,000
Deferred rent liability	6,000	11,000
Income under license agreement - Royalty income	78,000	98,000
Sale of patents	$4,000	$433,000

7_Stockholders_Equity_DetailsO

7. Stockholders' Equity (Details-Options Outstanding) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Equity [Abstract]
Number of Options Outstanding, Beginning	839,400	1,003,650
Number of Options Granted	0	0
Number of Options Exercised	0	0
Number of Options Forfeited	-30,500	-164,250
Number of Options Outstanding, Ending	808,900	839,400
Number of Options Exercisable	754,500
Weighted Average Exercise Price Outstanding, Beginning	$0.20	$0.23
Weighted Average Exercise Price Forfeited	$0.17	$0.34
Weighted Average Exercise Price Outstanding, Ending	$0.20	$0.20
Weighted Average Exercise Price, Options Exercisable	$0.21
Weighted Average Remaining Contractual Life (in years) Outstanding	3 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years) Exercisable	3 years 2 months 12 days
Aggregate Intrinsic Value Outstanding, Ending	$5,500
Aggregate Intrinsic Value Exercisable	$5,500

7_Stockholders_Equity_DetailsO1

7. Stockholders' Equity (Details-Option Summary) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Number of Options Outstanding, Ending	808,900	839,400	1,003,650
Weighted-Average Remaining Contractual Life (years)	3 years 4 months 24 days
Weighted Average Exercise Price Outstanding, Ending	$0.20	$0.20	$0.23
Number of Options Exercisable	754,500
Weighted Average Exercise Price, Options Exercisable	$0.21
Range $0.05-0.13 [Member]
Range of Exercise Prices, minimum	$0.05
Range of Exercise Prices, maximum	$0.13
Number of Options Outstanding, Ending	265,000
Weighted-Average Remaining Contractual Life (years)	2 years 9 months 18 days
Weighted Average Exercise Price Outstanding, Ending	$0.10
Number of Options Exercisable	265,000
Weighted Average Exercise Price, Options Exercisable	$0.10
Range $0.14-0.50 [Member]
Range of Exercise Prices, minimum	$0.14
Range of Exercise Prices, maximum	$0.50
Number of Options Outstanding, Ending	424,000
Weighted-Average Remaining Contractual Life (years)	4 years 6 months
Weighted Average Exercise Price Outstanding, Ending	$0.17
Number of Options Exercisable	369,900
Weighted Average Exercise Price, Options Exercisable	$0.17
Range $0.51-0.64 [Member]
Range of Exercise Prices, minimum	$0.51
Range of Exercise Prices, maximum	$0.64
Number of Options Outstanding, Ending	119,900
Weighted-Average Remaining Contractual Life (years)	8 months 12 days
Weighted Average Exercise Price Outstanding, Ending	$0.58
Number of Options Exercisable	119,900
Weighted Average Exercise Price, Options Exercisable	$0.58

7_Stockholders_Equity_Details_

7. Stockholders' Equity (Details Narrative) (2003 Plan [Member])	Sep. 30, 2014	Sep. 30, 2013
2003 Plan [Member]
Shares reserved for issuance	2,000,000
Shares available for issuance	1,191,100	1,160,600

8_Employee_Benefit_Plan_Detail

8. Employee Benefit Plan (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Compensation and Retirement Disclosure [Abstract]
Annual contributions to the Retirement Plan	$17,000	$20,000

9_Segment_Information_DetailsI

9. Segment Information (Details-Income Statement) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Revenue	$5,461,000	$5,989,000
Cost of sales	3,514,000	3,621,000
Gross profit	1,947,000	2,368,000
Expenses:
Selling, general and administrative	1,942,000	2,329,000
Research and development	471,000	407,000
Income (loss) from operations	-466,000	-368,000
Other:
Royalty income	78,000	98,000
Interest expense	-10,000	-2,000
Net gain on disposal of assets	0	8,000
Settlements and other	24,000	610,000
Income (loss) before provision for income taxes	-374,000	346,000
Provision for income taxes	7,000	17,000
Net income ( loss)	-381,000	329,000
Products [Member]
Revenue	2,950,000	3,130,000
Cost of sales	1,776,000	1,721,000
Gross profit	1,174,000	1,409,000
Expenses:
Selling, general and administrative	1,335,000	1,647,000
Research and development	471,000	407,000
Income (loss) from operations	-632,000	-645,000
Service and rental [Member]
Revenue	2,511,000	2,859,000
Cost of sales	1,738,000	1,900,000
Gross profit	773,000	959,000
Expenses:
Selling, general and administrative	607,000	682,000
Research and development	0	0
Income (loss) from operations	$166,000	$277,000

9_Segment_Information_DetailsS

9. Segment Information (Details-Sales in Foreign Countries) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Total Sales	$1,240,000	$1,136,000
Asia [Member]
Total Sales	969,000	551,000
Europe [Member]
Total Sales	70,000	304,000
Latin America [Member]
Total Sales	131,000	245,000
Middle East [Member]
Total Sales	1,000	3,000
Australia [Member]
Total Sales	65,000	31,000
Other Countries [Member]
Total Sales	$4,000	$2,000

9_Segment_Information_DetailsS1

9. Segment Information (Details-Similar Products) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Products:
Total Sales	$5,461,000	$5,989,000
Gross profit
Total gross profit	1,947,000	2,368,000
Lasers and accessories [Member]
Products:
Total Sales	759,000	504,000
Gross profit
Total gross profit	143,000	79,000
Fibers, Needles and Switch Tips [Member]
Products:
Total Sales	2,191,000	2,626,000
Gross profit
Total gross profit	1,031,000	1,330,000
Service and rental [Member]
Products:
Total Sales	2,511,000	2,859,000
Gross profit
Total gross profit	$773,000	$959,000

9_Segment_Information_Details_

9. Segment Information (Details Narrative) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Total segment assets	$4,711,000	$4,701,000
Products [Member]
Total segment assets	3,070,000
Service and rental [Member]
Total segment assets	1,616,000
Additions of property and equipment	$4,000	$52,000

10_RelatedParty_Transactions_D

10. Related-Party Transactions (Details Narrative) (Gastrodyne [Member], USD $)	Sep. 30, 2014
Gastrodyne [Member]
Shares purchased in another company	3,000,000
Purchase price of shares	$30,000
Investment percentage owned	30.00%